FDA Adverse Event Injury Summary report: N

ASR ACETABULAR CUPS 52

MDR report key: 2250885 · Received September 16, 2011

Report

Report Number
1818910-2011-18336
Event Type
Injury
Date Received
September 16, 2011
Report Date
August 18, 2011
Manufacturer
DEPUY INTERNATIONAL
Product Code
KWA
Removal / Correction Number
Z1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
LA, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

DEPUY STILL CONSIDERS THIS INVESTIGATION CLOSED.

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN (B)(6) 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Description of Event or Problem · 1

LITIGATION PAPERS ALLEGE: ON (B)(6) 2008, PATIENT WAS IMPLANTED WITH A DEPUY ASR HIP ON HER RIGHT SIDE. SHE HAS SUFFERED PAIN, SWELLING, INFLAMMATION, AND DAMAGE TO THE BONE AND TISSUE SURROUNDING THE IMPLANT. SHE MAY REQUIRE REVISION SURGERY. UPDATE: (B)(6) 2012 - THE SALES REP HAS REPORTED THE REVISION SURGERY. REPORT STATES THAT PATIENT HAD NO SYMPTOMS.

Description of Event or Problem · 1

LITIGATION PAPERS ALLEGE: ON (B)(6) 2008, PATIENT WAS IMPLANTED WITH A DEPUY ASR HIP ON HER RIGHT SIDE. SHE HAS SUFFERED PAIN, SWELLING, INFLAMMATION, AND DAMAGE TO THE BONE AND TISSUE SURROUNDING THE IMPLANT. SHE MAY REQUIRE REVISION SURGERY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ASR ACETABULAR CUPS 52 HIP KWA DEPUY INTERNATIONAL 2622694

Patients

Seq Age Sex Outcome Treatment
1